Nuvation Bio prices $250M convertible notes offering due 2032 Jun 25, 2026 11:59PM
Nuvation Bio Announces Pricing of Upsized Offering of $250.0 million of Convertible Senior Notes Jun 25, 2026 11:58PM
Nuvation Bio plans $200M convertible notes offering due 2032 Jun 25, 2026 07:02AM
Nuvation Bio Announces Proposed Convertible Senior Notes Offering Jun 25, 2026 07:00AM
RBC Capital: 'On balance we think readthroughs from the GSK acquisition of NUVB's key competitor are positive' Jun 9, 2026 11:32AM


May 5, 2026 04:05PM Nuvation Bio to Participate in Upcoming Investor Conferences
Apr 6, 2026 07:04AM Nuvation Bio Inc (NUVB) PT Raised at RBC Capital; ' High-reward opportunity looks compelling'
Sep 11, 2025 08:18AM RBC Capital on Biotech Shares: 'Company-Specific Volatility For Quality Names May Be Overdone'
Jun 17, 2025 10:13AM Nuvation Bio Inc (NUVB) PT Lowered to $6 at RBC Capital
May 12, 2025 04:05PM Nuvation Bio to Participate in Upcoming Investor Conferences
Jan 13, 2025 12:50PM RBC Capital Explores Biotech Implications Following Cavazzoni's Departure from the FDA
Apr 17, 2024 07:06AM Nuvation Bio Inc (NUVB) PT Raised to $5 at RBC Capital
Apr 6, 2021 08:26AM RBC Capital Starts Nuvation Bio Inc (NUVB) at Outperform